Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851
Go back to Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.24 -0.02 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.26 | 52 Week High | $19.62 | |||
| Open | $2.25 | 52 Week Low | $7.65 | |||
| Day High | $2.26 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $-0.22 | |||
| Volume | 1,044,611 | |||||
